Non-alcoholic Fatty Liver Disease and the Gut Microbiota: Exploring the Connection
Journal Title: Gastro - Open Journal - Year 2015, Vol 1, Issue 2
Abstract
As the gut microbiota continues to be implicated in an increasing number of disease processes, a plethora of new literature surrounding its complexity and role in the maintenance of intestinal homeostasis has become available. Non-alcoholic fatty liver disease (NAFLD) has become the most common nonviral liver disease worldwide and a number of predisposing risk factors for NAFLD have been identified, including obesity and insulin resistance. Recent evidence supports a role for the gut microbiota in the pathogenesis of these risk factors and NAFLD, itself. Additionally, changes in the gut microbiota can lead to activation of immune responses that have the potential to promote progression of NAFLD to the more severe Nonalcoholic steatohepatitis (NASH). Furthermore, the gut microbiota may serve as a potential target for therapeutic options to treat NAFLD. This review seeks to explain the role of the gut microbiota in the pathogenesis of NAFLD and its risk factors, while also discussing potential future treatment options directed at correcting imbalances with in the gut microbiota.
Authors and Affiliations
David A. Johnson
Keywords
Related Articles
- EP ID EP555907
- DOI 10.17140/GOJ-1-107
- Views 125
- Downloads 0
Coalescent Cyclical Vomiting: A Manifestation of Narcotic Bowel Syndrome?
This illustrative case suggests mechanisms that may contribute to disease progression and complications in adults with Cyclical Vomiting Syndrome (CVS). Symptoms initially followed a characteristic pattern in the context...
Capsule Endoscopy: Indications, Findings and Complications among Patients with Suspected Small Bowel Lesions
Background/Aims: Until a few years back, evaluation of small bowel pathology was unsatisfactory because of the inability to completely visualize the small bowel mucosa with the available endoscopic and radiological techn...
Endoscopy: From Diagnosis to Therapeutics
Two decades ago, gastroenterologists used endoscopy for the diagnosis of Gastrointestinal (GI) lesions, thereby helping surgeons to localize lesion that necessitated resection and treatment with surgery. Today, the gastr...
The Histamine H4 Receptor: A Novel Target for Safe Anti-inflammatory Drugs?
The functional role of histamine H4 receptors (H4Rs) in the Gastrointestinal (GI) tract is reviewed, with particular reference to their involvement in the regulation of gastric mucosal defense and inflammation. H4Rs have...
Percutaneous Endoscopic Gastrostomy: Use and Abuse in Clinical Practice
Nowadays, Percutaneous Endoscopic Gastrostomy (PEG) is considered the method of choice for long-term enteral feeding, and is spreading all over the world because of its effectiveness and easy carrying out. This review en...